Business
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
Escala Medical Ltd. ("Escala"), a medical technology company specializing in innovative repair solutions for women with Pelvic Organ Prolapse (POP), today announced the successful completion of a $4.5 million funding round. The investment included the EIC Fund, following a €2.5 million grant awarded to Escala in October 2023 through the prestigious EIC Accelerator program. The round also included participation from private investors in the United States and Israel.
About this update from Trendlines Group Ltd.
[{"type":"text","content":" Co-financing by the EIC Fund to ramp up women's health solution to POP","length":74,"tagName":"p"},{"type":"text","content":"MISGAV, Israel, June 30, 2025 /PRNewswire/ -- Escala Medical Ltd. ("Escala"), a medical technology company specializing in innovative repair solutions for women with Pelvic Organ Prolapse (POP), today announced the successful completion of a $4.5 million funding round. The investment included the EIC Fund, following a €2.5 million grant awarded to Escala in October 2023 through the prestigious EIC Accelerator program. The round also included participation from private investors in the United States and Israel.","length":525,"tagName":"p"},{"type":"image","alt":"At left: The Escala Medical R&D team in Israel. At right: Escala Medical CEO Edit Goldberg with the Escala US sales and marketing team.","displaySize":"","headline":null,"caption":"At left: The Escala Medical R&D team in Israel. At right: Escala Medical CEO Edit Goldberg with the Escala US sales and marketing team.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":284,"url":"https://media.zenfs.com/en/prnewswire.com/30b8848c8fd52257802b7cbb587f82e9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/aChBo25uypPibwBQB_MF8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUwMTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/30b8848c8fd52257802b7cbb587f82e9","width":400,"height":284}},"href":"https://mma.prnewswire.com/media/2721711/Escala_Medical_Ltd.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The funds will be used to expand Escala's commercial operations in the U.S., where the company's flagship device has been FDA-approved and commercially launched in 2023. To date, hundreds of successful procedures have been performed using the device. The funding will also support preparations for market entry into Europe, pending CE approval, as well as additional international growth through a newly signed distribution agreement with a Singapore-based partner covering Southeast Asia.","length":497,"tagName":"p"},{"type":"text","content":""This funding marks an important milestone as we continue to scale our operations and bring our breakthrough technology to more women worldwide," stated Dr. Edit Goldberg, CEO of Escala. "We're proud to have the support of t...